Stefanie D.

As a group of experienced, diverse, and inclusive professionals we have been investing in healthcare startups across Europe over the last 8 years. We have built, and continue to grow, a diverse portfolio of investments across the various fields of therapeutics, diagnostics and digital health. Through our broad presence in the European Healthcare field, we are also able to facilitate investment activities for institutional investors with our curated healthcare deals. We value close personal dialogue with diverse startup teams and bring smart money to the table. Startups have access to a large group of experts in all areas and regions, and if we invest, to a longterm engagement and commitment from us.

Rising Tide Europe is a global movement to increase women’s participation in angel investing which is at just 7%. It started in 2015 as a cooperative effort between GoBeyond and EBAN with support from Next Wave Impact. We strive to create opportunities for women to thrive in their professional and personal lives by promoting financial knowledge and increasing women’s access to an important asset class through a portfolio of early-stage companies.

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion. Read our community engagement guidelines: http://bit.ly/4ofoggc

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

As a group of experienced, diverse, and inclusive professionals we have been investing in healthcare startups across Europe over the last 8 years. We have built, and continue to grow, a diverse portfolio of investments across the various fields of therapeutics, diagnostics and digital health. Through our broad presence in the European Healthcare field, we are also able to facilitate investment activities for institutional investors with our curated healthcare deals. We value close personal dialogue with diverse startup teams and bring smart money to the table. Startups have access to a large group of experts in all areas and regions, and if we invest, to a longterm engagement and commitment from us.

Rising Tide Europe is a global movement to increase women’s participation in angel investing which is at just 7%. It started in 2015 as a cooperative effort between GoBeyond and EBAN with support from Next Wave Impact. We strive to create opportunities for women to thrive in their professional and personal lives by promoting financial knowledge and increasing women’s access to an important asset class through a portfolio of early-stage companies.